Compare BDX & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | ROP |
|---|---|---|
| Founded | 1897 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 33.4B |
| IPO Year | 1997 | 2002 |
| Metric | BDX | ROP |
|---|---|---|
| Price | $156.14 | $338.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $186.00 | ★ $492.60 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.89% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.25 | ★ 4.87 |
| Revenue | ★ $21,840,000,000.00 | $7,902,500,000.00 |
| Revenue This Year | N/A | $8.80 |
| Revenue Next Year | $3.02 | $6.73 |
| P/E Ratio | $604.88 | ★ $68.29 |
| Revenue Growth | 8.24 | ★ 12.26 |
| 52 Week Low | $140.11 | $305.96 |
| 52 Week High | $213.08 | $575.77 |
| Indicator | BDX | ROP |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 56.03 |
| Support Level | $153.27 | $310.28 |
| Resistance Level | $159.79 | $342.25 |
| Average True Range (ATR) | 3.73 | 8.72 |
| MACD | 0.93 | 0.90 |
| Stochastic Oscillator | 94.70 | 84.88 |
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.